The market faces challenges such as high costs of sophisticated devices and rural preference for traditional methods, but ...
That is a sizeable increase on Pfizer's September offer of $47.50 upfront and $22.50 in CVRs, which combined to give a deal ...
6don MSN
To Save His Hairline, One Man Tried Every Hair-Loss Treatment Going – Here's What Actually Works
From fish DNA injections to LED helmets, our writer tests the latest hair-loss treatments in search of thicker hair and ...
Irish Examiner on MSN
Prostate cancer: Get to know your treatment and testing options
Medical practitioners are constantly updating and refining approaches to prostate cancer care, while new cutting-edge ...
APPLIN: After nearly 20 years in HIV care, I’ve seen that HIV follows people through every season of life. When life is stable, patients stay in care and maintain suppression, but when challenges ...
First, always check with your doctor to make sure it’s safe for you. If it is, start small — just ten minutes a day. Then add another ten minutes later. You don’t have to walk for 30 minutes straight ...
Wall Street expected sales of Yeztugo, which has an annual U.S. list price of about $28,000, at $37.5 million, according to ...
Generated $459 million in 3Q 2025 revenues, including $178 million in U.S. net product salesReceived 152 new patient start forms for EMPAVELI® ...
18hon MSNOpinion
Opinion | The Rich Get Fit, And Poor Get 'Lectures' - That's India's Ozempic Problem
The rise of a grey market in India, where unsupervised doses are sold at exorbitant rates, demonstrates that excessive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback